市場調查報告書
商品編碼
1470633
吸入器和霧化器市場:按產品、適應症、分銷型態分類 - 2024-2030 年全球預測Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年吸入器和霧化器市場規模為93億美元,預計2024年將達到114.5億美元,2030年將達到386.3億美元,複合年成長率為22.55%。
吸入器是一種緊湊的攜帶式醫療設備,可將藥物直接輸送到肺部。吸入器有多種形式;定量吸入器 (MDI) 以氣霧劑的型態釋放固定型態的藥物,而乾粉吸入器 (DPI) 以患者吐出的乾粉型態輸送藥物。霧化器是一種電子設備,可將液體藥物變成細霧,患者可以透過面罩或吸嘴吸入。患有呼吸道疾病的患者主要使用吸入器和霧化器來給藥。由於污染和吸煙習慣導致呼吸系統疾病的發病率不斷增加,以及人們對呼吸系統疾病早期診斷和治療必要性的認知不斷增強,對吸入器和霧化器的需求不斷增加。然而,先進吸入器技術的高成本、藥物依從性的複雜性以及患者正確使用吸入器設備時的錯誤限制了吸入器和霧化器的普及。也就是說,與數位功能整合的智慧吸入器的開拓,以監控使用模式和提高合規性,以及可自訂選項的出現,以改善用戶體驗,正在推動吸入器和霧化器市場的範圍在全球範圍內擴大。
主要市場統計 | |
---|---|
基準年[2023] | 93億美元 |
預測年份 [2024] | 114.5億美元 |
預測年份 [2030] | 386.3億美元 |
複合年成長率(%) | 22.55% |
產品 廣泛使用吸入器來克服呼吸道疾病的負擔
吸入器是一種手持式設備,可將藥物以霧狀或粉末狀直接輸送到肺部。乾粉吸入器 (DPI) 以乾燥的細粉形式輸送藥物。患者透過吹嘴深深地吸氣到肺部。 DPI 通常用於長期維持治療,由於其易於使用和攜帶而受到一些患者的青睞。定量吸入器是常用的吸入器,其含有懸浮在加壓罐內的推進劑中的藥物。當您按下藥罐時,一定量的藥物會以氣霧劑的形式釋放,並被吸入肺部。霧化器是醫療設備,用於以霧狀將藥物吸入肺部。與同時輸送單一劑量的吸入器不同,霧化器可以在幾分鐘內連續輸送藥物。噴射霧化器或壓縮機霧化器使用壓縮空氣將液體藥物變成細霧。噴射霧化器通常用於臨床和家庭環境,但由於其尺寸和需要空氣壓縮機,它們的噪音相對較大且不太攜帶。網狀霧化器是一種新型霧化器,使用細網產生藥霧。篩孔式噴霧器採用電池供電且方攜帶帶,非常適合外食或需要外服藥的患者。超音波霧化器利用高頻聲波產生振動,將藥物變成細霧。超音波霧化器並不適合所有藥物,因為超音波產生的熱量會劣化某些化合物。
展示:消費者越來越偏好吸入器和霧化器來治療氣喘
氣喘是一種慢性肺部疾病,因氣道狹窄而導致呼吸急促、喘息、胸悶和咳嗽。氣喘患者選擇吸入器和霧化器通常取決於年齡、氣喘嚴重程度、易用性和患者偏好等因素。慢性阻塞性肺病會導致氣流阻塞和呼吸相關問題。治療通常涉及長效支氣管擴張劑、吸入性皮質類固醇和其他控制症狀的藥物。氣喘治療傾向於使用更廣泛的短效藥物來進行急性管理和症狀控制。另一方面,慢性阻塞性肺病的治療更著重於長效藥物來控制慢性症狀。
區域洞察
由於呼吸系統疾病的高發生率、政府的核准以及新穎產品系列的開發,美洲是一個高度新興和標準化的市場。美洲客戶的購買行為受到技術進步和投資創新輸送系統的大型製藥供應商的強烈影響。在亞太地區,對醫療保健基礎設施和當地藥品製造的投資正在推動吸入器和霧化器市場的成長。龐大的人口、不斷增加的呼吸系統疾病發病率以及學名藥的使用趨勢正在擴大亞太地區吸入器和霧化器市場的範圍。歐洲市場複雜、監管嚴格,先進吸入器設備的普及很高。對患者依從性和易用性的關注正在推動全部區域對智慧連網型吸入器的需求。非洲是一個呼吸系統疾病負擔較高的新興市場,但獲得醫療設施的機會有限。全部區域的高淨值客戶群見證了醫療保健支出的增加以及對優質醫療保健服務和產品的渴望。
FPNV定位矩陣
FPNV定位矩陣對於評估吸入器和霧化器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對吸入器和霧化器市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.吸入器/霧化器市場的市場規模和預測是多少?
2.吸入器和霧化器市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.吸入器/霧化器市場的技術趨勢和法規結構是什麼?
4.吸入器/霧化器市場主要供應商的市場佔有率是多少?
5.進入吸入器/霧化器市場的適當型態和策略性手段是什麼?
[192 Pages Report] The Inhalers & Nebulizers Market size was estimated at USD 9.30 billion in 2023 and expected to reach USD 11.45 billion in 2024, at a CAGR 22.55% to reach USD 38.63 billion by 2030.
Inhalers are compact, portable medical devices that deliver medication directly into the lungs. Inhalers come in various forms, including metered-dose inhalers (MDIs), which release a specific amount of medication in aerosol form, and dry powder inhalers (DPIs), which dispense medication in a dry powder form triggered by the patient's inhalation. Nebulizers are electronic devices that transform liquid medication into a fine mist, allowing patients to inhale the substance through a face mask or mouthpiece. Patients with respiratory diseases primarily use inhalers and nebulizers for medication administration. The increase in incidences of respiratory diseases due to pollution and smoking habits and growing awareness about the need for early diagnosis and treatment of respiratory conditions has improved the need for inhalers & nebulizers. However, the high cost of advanced inhaler technologies, the complexity of medication adherence, and patient errors in using inhaler devices correctly limit the penetration of inhalers & nebulizers. Nevertheless, the development of smart inhalers integrated with digital capabilities for monitoring usage patterns and improving compliance and the emergence of customizable options to enhance user experience is expanding the scope of the inhalers & nebulizers market worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 9.30 billion |
Estimated Year [2024] | USD 11.45 billion |
Forecast Year [2030] | USD 38.63 billion |
CAGR (%) | 22.55% |
Product: Wide availability of inhalers to overcome the respiratory disease burden
Inhalers are handheld devices that deliver medication as a mist or powder directly to the lungs. Dry powder inhalers (DPI) deliver medication as a dry, micronized powder. The patient inhales the powder deeply into the lungs through the device's mouthpiece. DPIs are often used for long-term maintenance therapy and are preferred by some patients due to their ease of use and portability. Metered dose inhalers are the commonly used inhalers and consist of a pressurized canister containing medication suspended in a propellant. When the canister is pressed down, it releases a fixed dose of the medicine in aerosol form, inhaled into the lungs. Nebulizers are medical devices used to administer medicine in the form of a mist inhaled into the lungs. Unlike inhalers, which deliver a single dose simultaneously, nebulizers can continuously deliver medication over several minutes. Jet or compressor nebulizers use compressed air to convert liquid drugs into fine mist. Jet nebulizers are commonly used in clinical and home settings but can be relatively noisy and less portable due to their size and the need for an air compressor. Mesh nebulizers are newer nebulizers that use fine mesh to produce medicinal mist. Mesh nebulizers are battery-operated and portable, making them ideal for patients who are mobile or need to administer medication while away from home. Ultrasonic nebulizers utilize high-frequency sound waves to generate vibrations that convert liquid medication into a fine mist. Ultrasonic nebulizers may not be suitable for all medications as the heat generated by the ultrasonic waves could potentially degrade certain compounds.
Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
Asthma is a chronic lung disease indicated by the narrowing of the airways, causing shortness of breath, wheezing, chest tightness, and coughing. The choice between inhalers and nebulizers for asthma patients often depends on factors such as age, severity of asthma, ease of use, and patient preference. Chronic obstructive pulmonary disease causes airflow blockage and breathing-related problems. Treatment usually involves long-acting bronchodilators, inhaled steroids, and other medications to manage symptoms. Asthma treatment tends to involve a broader array of short-acting medications for acute management and control of symptoms. In contrast, COPD treatments focus more on long-acting medicines to manage chronic symptoms.
Regional Insights
The Americas represents a highly developing and standardized inhalers & nebulizers market due to the high prevalence of respiratory diseases, supportive government approvals, and development of novel product portfolios. Customer purchasing behavior in the Americas is strongly influenced by technological advancements and the presence of major pharmaceutical vendors investing in innovative delivery systems. Asia-Pacific's investment in healthcare infrastructure and local pharmaceutical manufacturing fosters the growth of the inhalers & nebulizers market. A vast population and a rising incidence of respiratory conditions with an increasing trend in the use of generic drugs have expanded the scope of inhalers & nebulizers market in the Asia-Pacific. The European market is sophisticated, with stringent regulations and high penetration of advanced inhaler devices. The focus on patient compliance and ease of use drives the demand for smart and connected inhalers across the EMEA region. Africa is an emerging market with a high burden of respiratory diseases but has limited access to healthcare facilities. The increasing healthcare expenditure and desire for premium healthcare services and products are noticeable among the affluent customer segment across the EMEA region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Inhalers & Nebulizers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalers & Nebulizers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AMIKO Digital Health, AptarGroup, Inc., Beurer GmbH, Beximco Pharmaceuticals Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Dr Trust by Nureca Ltd., Drive DeVilbiss International, GF Health Products, Inc., GlaxoSmithKline PLC, H&T Presspart, ICONOVO AB, Koninklijke Philips N.V., Merck Group, Mundipharma GmbH, Narang Medical Limited, Novartis AG, Omron Corporation, PARI GmbH, Sensirion AG, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Vectura Group Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Inhalers & Nebulizers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalers & Nebulizers Market?
3. What are the technology trends and regulatory frameworks in the Inhalers & Nebulizers Market?
4. What is the market share of the leading vendors in the Inhalers & Nebulizers Market?
5. Which modes and strategic moves are suitable for entering the Inhalers & Nebulizers Market?